Kymriah (tisagenlecleucel)
pCPA File Number:
22470
Negotiation Status:
Concluded with an LOI
Indication(s):
Follicular lymphoma (FL), Relapsed or refractory, grade 1, 2 or 3a, in adult patients after two or more lines of systemic therapy
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
PG0306-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: